Shows effective removal of pharmaceuticals and pathogens in hospital wastewater, suggesting viable treatment options.
BACKGROUND Hospital premises generate wastewater containing a wide spectrum of contaminants, such as pharmaceutically active compounds ( PhACs ), antibiotic resistance genes ( ARGs ) and pathogenic microorganisms, whilst plenty of them are classified under the antibiotic resistant bacteria ( ΑRΒ ) category. These contaminants are of great concern, as they could have serious repercussions to the environment and public health. In the current study, a pilot‐scale unit based on Advanced Oxidation Processes ( AOPs ), was installed and operated on hospital's premises, in order to treat a highly contaminated stream of real hospital wastewater (HWW), evaluating: UV/H 2 O 2 , UV/TiO 2 ‐A, UV/TiO 2 ‐B, UV/H 2 O 2 + TiO 2 ‐A and UV/H 2 O 2 + TiO 2 ‐B at contact times of 6 and 11 h. RESULTS According to the results, 93 pharmaceuticals, parent compounds and metabolites, were detected and quantified using LC‐QTOF‐MS in the HWW produced in a building housing specific medical services. Their concentrations ranged between a few μg L −1 and several hundreds μg L −1 , while the concentrations of pathogens ranged from 10 3 to 10 6 CFUs 100 mL −1 . The removal rates of the sum of pharmaceuticals after 6 h of treatment were 44.6% and 40.4% for UV/H 2 O 2 and UV/TiO 2, respectively. Acute toxicity to Daphnia magna decreased after treatment; at 25% (v/v) HWW, the UV/H 2 O 2 effluent after 6 h caused 0% immobilization. In contrast, TiO₂‐based treatments remained toxic at 6 h, but toxicity was decreased after 11 h, with immobilization to 40–60% at 50% (v/v) HWW. Regarding the examined bacteria Enterococci, Escherichia coli, Klebsiella sp., and Staphylococcus sp. , both treatment processes achieved almost complete elimination. In contrast, although a decrease in the concentrations of ARGs was observed, they exhibited complex behaviour and remained in remarkable concentrations in the effluents. CONCLUSION: The results demonstrated that the applied processes have the potential to be implemented in the future for on‐site pre‐treatment of heavily contaminated HWW.
No takes yet. Share an insight, caveat, or question.
Kaliakatsos et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: